Clinical Trial Update: Intravenous TNK vs TPA for AIS Treatment on MSU,a Prospective Multicenter RCT [Phase 4]

View source ↗

Summary

A multicenter Phase 4 randomized trial comparing intravenous tenecteplase (TNK) with tissue plasminogen activator (alteplase) for acute ischemic stroke is curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Alteplase (alteplase)
• Tenecteplase (tenecteplase)

Snippet

Sponsor: Mahidol University | Conditions: Intravenous, Thrombosis | Phase 4 | Status: RECRUITING